Artielle ImmunoTherapeutics
Artielle ImmunoTherapeutics develops recombinant T-cell receptor ligands to treat T-cell-mediated inflammatory diseases.
Based based in San Francisco Bay Area, Silicon Valley, West Coast, Western US, Artielle ImmunoTherapeutics works in biopharma, biotechnology, therapeutics, founded in 2004.
As a business in biopharma, biotechnology, therapeutics, Artielle ImmunoTherapeutics is listed here with the public details available about it.
San Francisco Bay Area, Silicon Valley, West Coast, Western US is where the company is located.
Its current recorded stage is Convertible_Note.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $11.2M in funding.
| Sector | Biopharma, Biotechnology, Therapeutics |
|---|---|
| Headquarters | San Francisco Bay Area, Silicon Valley, West Coast, Western US |
| Founded | 2004 |
| Employees | c_00001_00010 |
| Stage | convertible_note |
| Total funding | $11,185,740 |
Website: www.artielle.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account